Moyamoya Syndrome Presenting with Ischemic Stroke Caused by Rapid Worsening of Vessel Stenosis Associated with Triple-seropositive Antiphospholipid Syndrome-Reference-Cited by-同舟云学术

Moyamoya Syndrome Presenting with Ischemic Stroke Caused by Rapid Worsening of Vessel Stenosis Associated with Triple-seropositive Antiphospholipid Syndrome

Published:2023-03-01 Issue:5 Volume:62 Page:793-796
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Oura Kazumasa¹,Yamaguchi Takashi¹,Suzuki Taro²,Yamaguchi Oura Mao¹,Itabashi Ryo¹,Maeda Tetsuya¹

Affiliation:

1. Division of Neurology and Gerontology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Japan

2. Department of Neurosurgery, Iwate Prefectural Ofunato Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/62/5/62_9316-22/_pdf

Reference15 articles.

1. 1. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. New Engl J Med 360: 1226-1237, 2009.

2. 2. Wang R, Xu Y, Lv R, Chen J. Systemic lupus erythematosus associated with moyamoya syndrome: a case report and literature review. Lupus 22: 629-633, 2013.

3. 3. Kim SJ, Heo KG, Shin HY, et al. Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study. Stroke 41: 173-176, 2010.

4. 4. Wang Z, Fu Z, Wang J, Cui H, Zhang Z, Zhang B. Moyamoya syndrome with antiphospholipid antibodies: a case report and literature review. Lupus 23: 1204-1206, 2014.

5. 5. Gašperšič N, Zaletel M, Kobal J, et al. Stroke and antiphospholipid syndrome-antiphospholipid antibodies are a risk factor for an ischemic cerebrovascular event. Clin Rheumatol 38: 379-384, 2019.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moyamoya Disease and Syndrome in Caucasian Patients;Cureus;2023-04-18